Verition Fund Management
OGEN icon

Verition Fund Management’s Oragenics OGEN Stock Holding History

Verition Fund Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed -$3K – 3173
2022
Q2 		$3K Hold
6
– – ﹤0.01% 2267
2022
Q1 		$3K Hold
6
– – ﹤0.01% 2667
2021
Q4 		$4K Hold
6
– – ﹤0.01% 2502
2021
Q3 		$6K Hold
6
– – ﹤0.01% 1846
2021
Q2 		$7K Hold
6
– – ﹤0.01% 1848
2021
Q1 		$9K Hold
6
– – ﹤0.01% 1509
2020
Q4 		$4K Hold
6
– – ﹤0.01% 1057
2020
Q3 		$6K Sell
6
-16
-73% -$25.6K ﹤0.01% 1023
2020
Q2 		$27K Sell
22
-6
-21% -$5.9K ﹤0.01% 1030
2020
Q1 		$29K Buy
+28
New +$26.9K ﹤0.01% 550

Other funds holding OGEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBF
Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Verition Fund Management's OGEN Position: Q3 2022 in Review

Verition Fund Management sold out of Oragenics (OGEN) in Q3 2022, closing a stake of 6 shares — an estimated $3K sold.

Verition Fund Management first reported a position in OGEN in Q1 2020 and held it in 10 quarters. The position peaked at $29K in Q1 2020. 25 funds tracked by Wall St. Rank hold OGEN as of Q3 2022.

  • Verition Fund Management reported no remaining Oragenics position as of Q3 2022 after selling out during the quarter.
  • Verition Fund Management sold 6 Oragenics shares in Q3 2022, an estimated $3K.
  • Verition Fund Management first reported a position in Oragenics in Q1 2020 and held it in 10 quarters.
  • Verition Fund Management's Oragenics position peaked at $29K in Q1 2020.
  • 25 funds tracked by Wall St. Rank held Oragenics as of Q3 2022.

Based on Verition Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.